Our results showed that the proportion of tumor immune cells (B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and dendritic cells) was significantly correlated with PPRC1 expression in 33 out of 38 tumor types. The gene discussed is CD4; the disease is neoplasm.